Your browser doesn't support javascript.
loading
An Unusual Case of LGI1 (Leucine-Rich Glioma-Inactivated Protein 1) Limbic Encephalitis With Anti-acetylcholine Receptor and Anti-striational Autoantibodies.
Pathak, Akash; Patel, Jay; Tran, Giselle; Mrlik, Matthew; Zhong, Ning; Lui, Forshing.
Afiliação
  • Pathak A; Neurology, California Northstate University College of Medicine, Elk Grove, USA.
  • Patel J; Neurology, California Northstate University College of Medicine, Elk Grove, USA.
  • Tran G; Neurology, California Northstate University College of Medicine, Elk Grove, USA.
  • Mrlik M; Neurology, California Northstate University College of Medicine, Elk Grove, USA.
  • Zhong N; Neurology, Kaiser Permanente Sacramento Medical Center, Sacramento, USA.
  • Lui F; Clinical Sciences, California Northstate University College of Medicine, Elk Grove, USA.
Cureus ; 15(10): e46491, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37927656
ABSTRACT
Autoimmune encephalitis (AE) results from immune-mediated damage to the central nervous system (CNS) with varying clinical manifestations depending on autoimmune antibodies present and the antigens they target. Leucine-rich glioma-inactivated protein 1 (LGI1) has been recognized as one of the leading causes of limbic encephalitis (LE), presenting with seizures, memory loss, and faciobrachial dystonic seizures. A better understanding of the unique presentations of these AE allows for quick and effective diagnosis and treatment. We are presenting a very unusual case of LGI1 autoimmune LE with two additional autoantibodies, anti-acetylcholine receptor (AChR) and anti-striational, in a patient with an underlying thymoma. We will discuss the pathophysiology and common clinical presentation of anti-LGI1 autoimmune LE.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article